Your browser doesn't support javascript.
loading
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.
Garassino, Marina C; Gadgeel, Shirish; Novello, Silvia; Halmos, Balazs; Felip, Enriqueta; Speranza, Giovanna; Hui, Rina; Garon, Edward B; Horinouchi, Hidehito; Sugawara, Shunichi; Rodriguez-Abreu, Delvys; Reck, Martin; Cristescu, Razvan; Aurora-Garg, Deepti; Loboda, Andrey; Lunceford, Jared; Kobie, Julie; Ayers, Mark; Piperdi, Bilal; Pietanza, M Catherine; Paz-Ares, Luis.
Affiliation
  • Garassino MC; Section of Hematology/Oncology, Thoracic Oncology program, University of Chicago, Chicago, Illinois, and IRCCS Istituto Nazionale dei Tumori, Milano.
  • Gadgeel S; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Health System, Detroit, Michigan.
  • Novello S; Department of Oncology, University of Turin, Orbassano, Italy.
  • Halmos B; Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
  • Felip E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University, Barcelona, Spain.
  • Speranza G; Centre integré de cancérologie de la Montérégie, Université de Sherbrooke, Greenfield Park, Quebec, Canada.
  • Hui R; Westmead Hospital and University of Sydney, Sydney, New South Wales, Australia.
  • Garon EB; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
  • Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
  • Rodriguez-Abreu D; Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Reck M; LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
  • Cristescu R; Merck & Co., Inc., Rahway, New Jersey.
  • Aurora-Garg D; Merck & Co., Inc., Rahway, New Jersey.
  • Loboda A; Merck & Co., Inc., Rahway, New Jersey.
  • Lunceford J; Merck & Co., Inc., Rahway, New Jersey.
  • Kobie J; Merck & Co., Inc., Rahway, New Jersey.
  • Ayers M; Merck & Co., Inc., Rahway, New Jersey.
  • Piperdi B; Merck & Co., Inc., Rahway, New Jersey.
  • Pietanza MC; Merck & Co., Inc., Rahway, New Jersey.
  • Paz-Ares L; Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid, Spain.
JTO Clin Res Rep ; 4(1): 100431, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36793385
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: JTO Clin Res Rep Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: JTO Clin Res Rep Year: 2023 Type: Article